retatrutide fda approval status october 2025 Warns Companies Over Compounded Retatrutide: What Healthcare Providers Should Know Retatrutide FDA Approval 2025–2026: Phase

Will I need prior authorization

GLP-1 medications, including Ozempic, offer powerful options for managing blood sugar and supporting weight loss, but determining the best choice depends on individual needs

As access becomes more difficult, were seeing the rise of compounded products, black-market peptides, and unregulated supplements that claim to mimic GLP-1s

Intestinal and brain cells contain prohormone convertase 1 (PC1), which is able to cleave proglucagon into Glicentin, Oxyntomodulin, GLP-1, GLP-2 and IP-2, while pancreatic islet cells contain prohormone convertase 2 (PC2), which capable of cleaving proglucagon into Glucagon and MPGF

This concern, combined with the risk of patent cliff and compounded pharmaceuticals/grey market peptides on GLP-1 manufacturer economics, caused us to exit the basket in November 2024